Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — CDNA

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Cash & Equivalents	250.48	373.64	77.92	65.43	91.44	68.21	88.75	114.69	95.40	95.78	93.30	82.20	75.98	87.79	74.66	89.92	82.96	166.83	171.89	348.49
Short-term Investments	0.00	0.00	109.25	111.78	102.78	118.04	142.17	145.96	145.45	133.09	122.62	153.22	192.20	194.89	211.28	203.17	208.32	139.39	147.33	0.00
Accounts Receivable	47.73	34.38	44.59	42.63	47.84	67.36	71.49	64.61	66.63	66.16	60.15	51.06	51.69	51.63	59.31	66.31	70.43	70.14	65.32	59.76
Inventory	9.14	6.98	26.40	26.71	28.33	27.92	22.93	19.50	19.26	19.23	20.13	19.47	17.98	18.84	18.02	19.23	18.09	18.86	18.21	17.19
Total Current Assets	321.30	429.22	269.40	257.13	300.28	307.30	350.24	351.83	334.09	320.61	303.10	313.71	345.17	360.81	371.43	387.85	388.16	403.88	411.49	433.36
Property, Plant & Equipment	27.01	26.84	33.16	32.97	30.85	31.93	32.73	33.55	34.02	34.20	34.41	35.25	35.35	36.08	35.51	35.53	34.05	32.90	27.56	22.04
Goodwill	121.71	35.97	40.34	40.34	40.34	40.34	40.34	40.34	40.34	40.34	40.34	40.34	40.21	39.66	39.62	37.52	37.52	37.08	36.98	36.98
Intangible Assets	136.29	15.06	28.61	28.47	29.95	32.54	33.75	34.68	36.85	38.02	39.58	41.73	42.64	42.28	44.39	41.80	42.61	45.07	46.90	48.95
Total Non-current Assets*	320.16	103.77	141.67	156.10	132.03	136.96	139.40	139.22	142.90	146.17	149.31	153.11	156.01	154.01	156.79	155.14	156.35	137.41	135.22	133.26
Total Assets	641.46	532.99	411.06	413.23	432.31	444.26	489.64	491.05	476.99	466.78	452.41	466.83	501.18	514.82	528.22	542.99	544.51	541.29	546.71	566.62
Accounts Payable	10.81	9.49	9.07	9.99	11.60	9.86	8.07	7.69	6.24	5.87	9.98	12.87	8.97	9.88	12.86	9.94	10.63	16.89	10.61	13.34
Total Current Liabilities	138.98	93.70	79.15	89.85	99.04	93.18	85.28	89.37	81.44	78.33	70.21	78.07	72.67	74.50	71.83	75.97	70.29	78.46	66.92	77.30
Long-term Debt	--	--	--	--	--	--	--	--	0.00	0.00	--	--	--	--	--	--	--	--	--	--
Total Non-current Liabilities*	35.03	13.69	18.37	20.28	22.12	23.71	25.01	23.25	122.30	123.78	125.97	127.43	34.37	35.11	36.37	36.10	37.54	19.28	22.25	23.44
Total Liabilities	174.00	107.39	97.53	110.13	121.17	116.89	110.29	112.62	203.74	202.11	196.18	205.50	107.05	109.61	108.20	112.08	107.83	97.74	89.17	100.75
Retained Earnings	(486.15)	(505.45)	(732.55)	(735.36)	(719.05)	(695.16)	(636.59)	(626.24)	(704.25)	(696.84)	(695.45)	(678.27)	(534.20)	(509.90)	(484.88)	(460.44)	(441.47)	(424.53)	(402.84)	(383.19)
Total Stockholder Equity	467.46	425.60	313.54	303.10	311.14	327.37	379.35	378.43	273.25	264.67	256.23	261.33	394.13	405.21	420.02	430.91	436.68	443.55	457.54	465.88

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	139.36	131.95	117.70	108.39	100.06	86.68	84.69	86.58	82.88	92.27	72.05	65.57	67.19	70.30	77.26	82.38	79.36	80.63	79.42	79.22
Research & Development	21.32	22.38	21.42	19.31	16.77	16.83	18.52	16.53	17.49	19.68	18.71	18.28	19.00	20.23	24.36	23.57	22.31	22.63	21.88	22.05
Selling, General & Admin	37.99	40.91	30.48	28.68	28.43	27.68	22.77	40.68	28.52	27.68	26.91	26.54	33.97	29.33	28.03	24.78	23.83	25.23	26.56	24.75
Total Operating Expenses	131.25	18.73	116.50	114.43	100.30	97.80	98.06	11.89	93.38	96.37	91.39	188.20	95.98	97.93	101.59	101.50	96.70	102.35	98.47	94.62
Operating Income	8.11	113.22	1.20	(6.04)	(0.25)	(11.12)	(13.37)	74.69	(10.49)	(4.10)	(19.34)	(122.63)	(28.78)	(27.62)	(24.32)	(19.12)	(17.34)	(21.72)	(19.05)	(15.40)
Pretax Income	10.69	114.52	2.78	(3.76)	1.66	(8.68)	(10.29)	78.18	(7.21)	(1.37)	(16.74)	(117.93)	(23.56)	(25.02)	(23.62)	(18.16)	(16.67)	(21.75)	(19.66)	(17.05)
Tax Provision	(8.60)	3.88	(0.03)	0.35	(0.01)	(0.12)	0.06	0.17	0.20	0.02	(0.08)	0.17	(0.08)	(0.07)	0.12	0.17	0.27	(0.05)	(0.01)	(0.90)
Net Income	19.29	110.64	2.81	(4.11)	1.68	(8.57)	(10.35)	78.01	(7.41)	(1.39)	(16.66)	(118.10)	(23.48)	(24.95)	(23.75)	(18.33)	(16.94)	(21.70)	(19.65)	(16.15)
Basic EPS	0.37	2.15	0.05	(0.08)	0.03	(0.16)	(0.19)	1.49	(0.14)	(0.03)	(0.32)	(2.21)	(0.43)	(0.46)	(0.44)	(0.34)	(0.32)	(0.41)	(0.37)	(0.31)
Diluted EPS	0.35	2.07	0.05	(0.08)	0.03	(0.16)	(0.19)	1.42	(0.14)	(0.03)	(0.32)	(2.21)	(0.43)	(0.46)	(0.44)	(0.34)	(0.32)	(0.41)	(0.37)	(0.31)

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	12.72	30.60	4.33	21.36	37.36	9.90	(26.58)	21.89	12.52	18.95	(15.31)	(8.38)	(10.18)	(0.50)	0.67	7.19	(7.08)	(3.88)	(21.47)	4.17
Capital Expenditures	1.62	1.86	3.82	--	--	--	--	--	--	--	--	1.80	1.80	--	--	--	--	--	--	--
Free Cash Flow*	11.10	28.75	0.51	--	--	--	--	--	--	--	--	(10.18)	(11.98)	--	--	--	--	--	--	--
Investing Cash Flow	(147.88)	280.59	11.06	(34.91)	12.35	23.40	1.33	(2.11)	(14.41)	(11.63)	27.66	41.37	(1.50)	15.35	(14.77)	2.48	(75.73)	0.79	(156.03)	(7.78)
Financing Cash Flow	12.90	(15.50)	(2.91)	(12.46)	(26.48)	(53.81)	(0.64)	(0.90)	1.42	(4.85)	(1.27)	(26.88)	(0.02)	(1.57)	(1.14)	(2.37)	(1.03)	(2.00)	0.87	(0.83)

← Scroll for more columns →

* Derived from reported values